Status:

COMPLETED

Anticoagulation in Chronic Hemodialysis Patients Versus Hemodialyzer Fiber Patency, Bleedings and Quality of Life

Lead Sponsor:

University Hospital, Ghent

Conditions:

Blood Coagulation

Eligibility:

All Genders

18+ years

Brief Summary

Stable chronic hemodialysis patients are included in this observational study. After a midweek dialysis (test moment 1), the hemodialyzer is dried and scanned in a micro Computed Tomography scanner to...

Detailed Description

All stable chronic hemodialysis (HD) patients having daytime dialysis in the Ghent University Hospital, are included. From the patient's record, data are collected: demographic data (i.e. age, weight...

Eligibility Criteria

Inclusion

  • treated with chronic daytime hemodialysis

Exclusion

  • no active infection at the time of inclusion

Key Trial Info

Start Date :

April 27 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2022

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT05365542

Start Date

April 27 2022

End Date

December 31 2022

Last Update

May 6 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ghent University Hospital

Ghent, Belgium, 9000

Anticoagulation in Chronic Hemodialysis Patients Versus Hemodialyzer Fiber Patency, Bleedings and Quality of Life | DecenTrialz